A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia

Journal of the American Academy of Dermatology

Volumn 70, Issue 3, 2014, Pages 489-498.e3

  Gubelin Harcha, Walter ^a   Barboza Martínez, Julia ^b   Tsai, Tsen Fang ^c   Katsuoka, Kensei ^d   Kawashima, Makoto ^e   Tsuboi, Ryoji ^f   Barnes, Allison ^g   Ferron Brady, Geraldine ^g   Chetty, Dushen ^h  

^a Centro Médico Skinmed   (Chile)

^b Unidad de Investigación Multidisciplinaria   (Peru)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d KITASATO UNIVERSITY   (Japan)

^e TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^f TOKYO MEDICAL UNIVERSITY   (Japan)

^g GLAXOSMITHKLINE   (United States)

^h GLAXOSMITHKLINE   (Singapore)

Author keywords

5 alpha reductase; 5 alpha reductase inhibitors; androgenetic alopecia; dutasteride; finasteride; male pattern baldness; male pattern hair loss; treatment

Indexed keywords

ANDROSTANOLONE; DUTASTERIDE; FINASTERIDE; PLACEBO;

ABDOMINAL PAIN; ADULT; ALLERGIC RHINITIS; ARTICLE; BACKACHE; BREAST DISEASE; BREAST TENDERNESS; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; EJACULATION DISORDER; ERECTILE DYSFUNCTION; HAIR ANALYSIS; HAIR GROWTH; HEADACHE; HUMAN; INFLUENZA; INTENTION TO TREAT ANALYSIS; LIBIDO DISORDER; MAJOR CLINICAL STUDY; MALE; MALE TYPE ALOPECIA; MIDDLE AGED; PHARYNGITIS; PHASE 3 CLINICAL TRIAL (TOPIC); PREMATURE EJACULATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; SEXUAL DYSFUNCTION; SEXUALITY; TREATMENT OUTCOME; UPPER ABDOMINAL PAIN; UPPER RESPIRATORY TRACT INFECTION; YOUNG ADULT;

5-ALPHA REDUCTASE; 5-ALPHA REDUCTASE INHIBITORS; ANDROGENETIC ALOPECIA; DUTASTERIDE; FINASTERIDE; MALE PATTERN BALDNESS; MALE PATTERN HAIR LOSS; TREATMENT;

ADULT; ALOPECIA; AZASTEROIDS; CONFIDENCE INTERVALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FINASTERIDE; FOLLOW-UP STUDIES; HAIR; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; REFERENCE VALUES; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84894075744     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2013.10.049     Document Type: Article

References (31)

1. T. Rhodes, C.J. Girman, R.C. Savin, K.D. Kaufman, S. Guo, and F.R. Lilly et al. Prevalence of male pattern hair loss in 18-49 year old men Dermatol Surg 24 1998 1330 1332 (Pubitemid 29018223)
2. J.H. Paik, J.B. Yoon, W.Y. Sim, B.S. Kim, and N.I. Kim The prevalence and types of androgenetic alopecia in Korean men and women Br J Dermatol 145 2001 95 99
3. T.L. Wang, C. Zhou, Y.W. Shen, X.Y. Wang, X.L. Ding, and S. Tian et al. Prevalence of androgenetic alopecia in China: a community-based study in six cities Br J Dermatol 162 2010 843 847
4. L.H. Su, and T.H. Chen Association of androgenetic alopecia with smoking and its prevalence among Asian men: a community-based survey Arch Dermatol 143 2007 1401 1406 (Pubitemid 350146267)
5. D. Pathomvanich, S. Pongratananukul, P. Thienthaworn, and S. Manoshai A random study of Asian male androgenetic alopecia in Bangkok, Thailand Dermatol Surg 28 2002 804 807 (Pubitemid 35014682)
6. P.H. Tang, H.P. Chia, L.L. Cheong, and D. Koh A community study of male androgenetic alopecia in Bishan, Singapore Singapore Med J 41 2000 202 205
7. C.L. Goh A retrospective study on the characteristics of androgenetic alopecia among Asian races in the National Skin Center, a tertiary dermatological referral center in Singapore Ann Acad Med Singapore 31 2002 751 755 (Pubitemid 36216159)
8. T.F. Cash The psychological effects of androgenetic alopecia in men J Am Acad Dermatol 26 1992 926 931
9. S.H. Han, J.W. Byun, W.S. Lee, H. Kang, Y.C. Kye, and K.H. Kim et al. Quality of life assessment in male patients with androgenetic alopecia: result of a prospective, multicenter study Ann Dermatol 24 2012 311 318
10. N. Sawant, S. Chikhalkar, V. Mehta, M. Ravi, B. Madke, and U. Khopkar Androgenetic alopecia: quality-of-life and associated lifestyle patterns Int J Trichology 2 2010 81 85
11. D. Stough, K. Stenn, R. Haber, W.M. Parsley, J.E. Vogel, and D.A. Whiting et al. Psychological effect, pathophysiology, and management of androgenetic alopecia in men Mayo Clin Proc 80 2005 1316 1322 (Pubitemid 41395965)
12. A. Sato, and A. Takeda Evaluation of efficacy and safety of finasteride 1 mg in 3177 Japanese men with androgenetic alopecia J Dermatol 39 2012 27 32
13. M. Kawashima, N. Hayashi, A. Igarashi, H. Kitahara, M. Maeguchi, and A. Mizuno et al. Finasteride in the treatment of Japanese men with male pattern hair loss Eur J Dermatol 14 2004 247 254 (Pubitemid 39024231)
14. J.H. Lin, and W.C. Chen Finasteride in the treatment of Taiwanese men with androgenetic alopecia: a 12-month open-label study Kaohsiung J Med Sci 18 2002 379 385
15. Finasteride Male Pattern Hair Loss Study Group Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia Eur J Dermatol 12 2002 38 49
16. K.J. McElwee, and J.S. Shapiro Promising therapies for treating and/or preventing androgenic alopecia Skin Therapy Lett 17 2012 1 4
17. W. Chen, C.C. Zouboulis, and C.E. Orfanos The 5 alpha-reductase system and its inhibitors: recent development and its perspective in treating androgen-dependent skin disorders Dermatology 193 1996 177 184 (Pubitemid 26361517)
18. A. Messenger Male androgenetic alopecia U. Blume-Peytavi, A. Tosti, D.A. Whiting, R. Trueb, Hair growth and disorders 2008 Springer Berlin 159 170
19. K.D. Kaufman Androgen metabolism as it affects hair growth in androgenetic alopecia Dermatol Clin 14 1996 697 711 (Pubitemid 26322538)
20. E.A. Olsen Androgenetic alopecia E.A. Olsen, Disorders of hair growth: diagnosis and treatment 1994 McGraw-Hill New York 257 283
21. A. Godoy, E. Kawinski, Y. Li, D. Oka, B. Alexiev, and F. Azzouni et al. 5Alpha-reductase type 3 expression in human benign and malignant tissues: a comparative analysis during prostate cancer progression Prostate 71 2011 1033 1046
22. T. Sato, T. Sonoda, S. Itami, and S. Takayasu Predominance of type I 5alpha-reductase in apocrine sweat glands of patients with excessive or abnormal odor derived from apocrine sweat (osmidrosis) Br J Dermatol 139 1998 806 810 (Pubitemid 28520286)
23. D. Thiboutot, G. Harris, V. Iles, G. Cimis, K. Gilliland, and S. Hagari Activity of the type 1 5 alpha-reductase exhibits regional differences in isolated sebaceous glands and whole skin J Invest Dermatol 105 1995 209 214
24. H.C. Eun, O.S. Kwon, J.H. Yeon, H.S. Shin, B.Y. Kim, and B.I. Ro et al. Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: a randomized, double-blind, placebo-controlled, phase III study J Am Acad Dermatol 63 2010 252 258
25. E.A. Olsen, M. Hordinsky, D. Whiting, D. Stough, S. Hobbs, and M.L. Ellis et al. The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride J Am Acad Dermatol 55 2006 1014 1023 (Pubitemid 44716474)
26. O.T. Norwood Male pattern baldness: classification and incidence South Med J 68 1975 1359 1365
27. D. Canfield Photographic documentation of hair growth in androgenetic alopecia Dermatol Clin 14 1996 713 721 (Pubitemid 26322539)
28. K.J. McClellan, and A. Markham Finasteride: a review of its use in male pattern hair loss Drugs 57 1999 111 126 (Pubitemid 29042022)
29. F. Debruyne, J. Barkin, P. van Erps, M. Reis, T.L. Tammela, and C. Roehrborn Efficacy and safety of long-term treatment with the dual 5 alpha-reductase inhibitor dutasteride in men with symptomatic benign prostatic hyperplasia Eur Urol 46 2004 488 495 (Pubitemid 39200858)
30. G.L. Andriole, D.G. Bostwick, O.W. Brawley, L.G. Gomella, M. Marberger, and F. Montorsi et al. Effect of dutasteride on the risk of prostate cancer N Engl J Med 362 2010 1192 1202
31. N. Monga, A. Sayani, D.A. Rubinger, T.H. Wilson, and Z. Su The effect of dutasteride on the detection of prostate cancer: a set of meta-analyses Can Urol Assoc J 7 2013 E161 E167